Structure-based drug designing and immunoinformatics approach for SARS-CoV-2

The prevalence of respiratory illness caused by the novel SARS-CoV-2 virus associated with multiple organ failures is spreading rapidly because of its contagious human-to-human transmission and inadequate globalhealth care systems. Pharmaceutical repurposing, an effective drug development technique...

Descripción completa

Detalles Bibliográficos
Autores principales: Panda, Pritam Kumar, Arul, Murugan Natarajan, Patel, Paritosh, Verma, Suresh K., Luo, Wei, Rubahn, Horst-Günter, Mishra, Yogendra Kumar, Suar, Mrutyunjay, Ahuja, Rajeev
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319274/
https://www.ncbi.nlm.nih.gov/pubmed/32691011
http://dx.doi.org/10.1126/sciadv.abb8097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319274/
https://www.ncbi.nlm.nih.gov/pubmed/32691011
http://dx.doi.org/10.1126/sciadv.abb8097

Ejemplares similares